Tema Neuroscience and Mental Health ETF (MNTL) Chart & Stock Price History → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free MNTL Stock Alerts $24.00 +0.22 (+0.93%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartHoldingsSocial MediaStock AnalysisChartHoldingsSocial Media Tema Neuroscience and Mental Health ETF Stock Price Performance5 Day Performance+0.50%1 Month Performance-8.12%3 Month Performance-4.90% Receive MNTL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tema Neuroscience and Mental Health ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsWhy Big Pharma is Investing Billions in This BiotechIf you're on the hunt for a great biotech stock under $20... you need to see this video.Watch my exclusive report here>>> MNTL Stock Chart for Saturday, April, 27, 2024 MNTL Chart by TradingView Tema Neuroscience and Mental Health ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$23.78$24.00+0.93%$24.00$23.83812 shs$10.56 million04/25/2024$24.07$23.78-1.20%$23.78$23.781 shs$10.46 million04/24/2024$24.19$24.07-0.50%$24.24$24.07405 shs$10.59 million04/23/2024$23.88$24.19+1.30%$24.19$24.03302 shs$10.64 million04/22/2024$23.67$23.88+0.88%$23.88$23.80205 shs$10.51 million04/19/2024$23.76$23.67-0.38%$23.67$23.6730 shs$10.42 million Get the Latest News and Ratings for MNTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Neuroscience and Mental Health ETF and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$23.98$23.76-0.92%$24.06$23.76732 shs$10.45 million04/17/2024$24.13$23.98-0.62%$24.12$23.98906 shs$10.55 million04/16/2024$24.16$24.13-0.14%$24.13$24.1343 shs$10.62 million04/15/2024$24.52$24.16-1.46%$24.68$24.16502 shs$10.63 million04/12/2024$25.10$24.52-2.31%$24.52$24.5260 shs$10.79 million04/11/2024$25.09$25.10+0.04%$25.18$25.10310 shs$11.04 million04/10/2024$25.42$25.09-1.30%$25.09$25.0920 shs$11.04 million04/09/2024$25.28$25.42+0.57%$25.48$25.42101 shs$11.19 million04/08/2024$25.40$25.28-0.50%$25.28$25.287 shs$11.12 million04/05/2024$25.13$25.40+1.07%$25.40$25.40110 shs$508,000.0004/04/2024$25.51$25.13-1.49%$25.13$25.13124 shs$503,000.0004/03/2024$25.40$25.51+0.42%$25.51$25.5122 shs$510,000.0004/02/2024$25.99$25.40-2.26%$25.78$25.40640 shs$508,000.0004/01/2024$26.14$25.99-0.56%$25.99$25.993 shs$520,000.0003/29/2024$26.14$26.14-0.02%$26.14$26.1475 shs$523,000.0003/28/2024$26.12$26.14+0.08%$26.14$26.1475 shs$523,000.0003/27/2024$25.77$26.12+1.36%$26.12$26.123 shs$522,000.0003/26/2024$25.70$25.77+0.27%$25.81$25.77604 shs$515,000.0003/25/2024$25.77$25.70-0.27%$25.75$25.70182 shs$514,000.0003/22/2024$25.93$25.77-0.62%$25.77$25.7711 shs$515,000.0003/21/2024$25.87$25.93+0.23%$25.93$25.9311 shs$519,000.0003/20/2024$25.70$25.87+0.66%$25.87$25.49813 shs$517,000.0003/19/2024$25.30$25.70+1.58%$25.70$25.705 shs$514,000.0003/18/2024$25.40$25.30-0.39%$25.30$25.3031 shs$506,000.0003/15/2024$25.33$25.40+0.28%$25.42$25.29459 shs$508,000.0003/14/2024$25.83$25.33-1.94%$25.33$25.336 shs$507,000.0003/13/2024$25.80$25.83+0.12%$25.83$25.8325 shs$517,000.0003/12/2024$25.89$25.80-0.35%$25.80$25.8025 shs$516,000.0003/11/2024$26.20$25.89-1.18%$25.89$25.899 shs$518,000.0003/08/2024$26.38$26.20-0.68%$26.24$26.201,242 shs$524,000.0003/07/2024$26.30$26.38+0.30%$26.38$26.38130 shs$528,000.0003/06/2024$26.26$26.30+0.15%$26.44$26.19497 shs$526,000.0003/05/2024$26.50$26.26-0.90%$26.47$26.26106 shs$525,000.0003/04/2024$26.61$26.50-0.43%$26.65$26.501,303 shs$530,000.00The A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself.03/01/2024$25.95$26.61+2.54%$26.61$26.61117 shs$532,000.0002/29/2024$26.32$25.95-1.41%$26.54$25.951,476 shs$519,000.0002/28/2024$26.71$26.32-1.46%$26.74$26.32239 shs$526,000.0002/27/2024$25.98$26.71+2.81%$26.71$26.7181 shs$534,000.0002/26/2024$25.75$25.98+0.91%$25.98$25.98122 shs$520,000.0002/23/2024$25.77$25.75-0.08%$25.86$25.751,662 shs$515,000.0002/22/2024$25.37$25.77+1.58%$25.77$25.773 shs$515,000.0002/21/2024$25.56$25.37-0.75%$25.37$25.371 shs$507,000.0002/20/2024$25.86$25.56-1.15%$25.91$25.561,064 shs$511,000.0002/19/2024$25.86$25.86-0.01%$26.06$25.86100 shs$517,000.0002/16/2024$25.87$25.86-0.04%$26.06$25.86120 shs$517,000.0002/15/2024$25.55$25.87+1.25%$25.87$25.874 shs$517,000.0002/14/2024$25.22$25.55+1.31%$25.55$25.38708 shs$511,000.0002/13/2024$26.07$25.22-3.26%$25.68$25.223,717 shs$504,000.0002/12/2024$25.95$26.07+0.47%$26.10$26.07111 shs$521,000.0002/09/2024$25.71$25.95+0.93%$25.96$25.95197 shs$0.0002/08/2024$25.52$25.71+0.74%$25.74$25.71112 shs$0.0002/07/2024$25.58$25.52-0.23%$25.52$25.5216 shs$0.0002/06/2024$25.27$25.58+1.23%$25.58$25.5856 shs$0.0002/05/2024$25.17$25.27+0.39%$25.27$25.272 shs$0.0002/02/2024$25.51$25.17-1.33%$25.17$25.17770 shs$0.0002/01/2024$25.13$25.51+1.51%$25.51$25.22770 shs$0.0001/31/2024$25.36$25.13-0.91%$25.45$25.13565 shs$0.0001/30/2024$25.70$25.36-1.32%$25.53$25.27127,109 shs$0.0001/29/2024$25.24$25.70+1.83%$25.70$25.173,509 shs$0.0001/26/2024$25.36$25.24-0.47%$25.35$25.23125,602 shs$0.00 Related Companies: VanEck Robotics ETF Stock Chart First Trust Indxx Global Agriculture ETF Stock Chart iShares ESG MSCI USA Min Vol Factor ETF Stock Chart Global X Clean Water ETF Stock Chart Invesco Electric Vehicle Metals Commodity Strategy No K-1 ETF Stock Chart Principal Millennial Global Growth ETF Stock Chart Fidelity Metaverse ETF Stock Chart SPAC and New Issue ETF Stock Chart BNY Mellon Women's Opportunities ETF Stock Chart Sprott Junior Copper Miners ETF Stock Chart Receive MNTL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tema Neuroscience and Mental Health ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MNTL) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressProtect Your Bank Account Before It’s Too LateWeiss RatingsJeff Bezos Just Humiliated Elon MuskInvestorPlace4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.